Group One Trading’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-20,000
| Closed | -$514K | – | 7405 |
|
|
2023
Q4 | $514K | Buy |
+20,000
| New | +$284K | ﹤0.01% | 3042 |
|
|
2021
Q4 | – | Sell |
-1,293
| Closed | -$40K | – | 8448 |
|
|
2021
Q3 | $40K | Sell |
1,293
-40
| -3% | -$1.32K | ﹤0.01% | 6710 |
|
|
2021
Q2 | $43K | Sell |
1,333
-2,720
| -67% | -$93.3K | ﹤0.01% | 6707 |
|
|
2021
Q1 | $153K | Buy |
+4,053
| New | +$185K | ﹤0.01% | 5271 |
|
|
2020
Q4 | – | Sell |
-133
| Closed | -$4K | – | 6694 |
|
|
2020
Q3 | $4K | Sell |
133
-1,334
| -91% | -$52.2K | ﹤0.01% | 5677 |
|
|
2020
Q2 | $65K | Buy |
1,467
+134
| +10% | +$6.29K | ﹤0.01% | 4196 |
|
|
2020
Q1 | $44K | Buy |
+1,333
| New | +$61.3K | ﹤0.01% | 3786 |
|
|
2018
Q4 | – | Sell |
-173
| Closed | -$14K | – | 5071 |
|
|
2018
Q3 | $14K | Buy |
173
+120
| +226% | +$9.51K | ﹤0.01% | 4533 |
|
|
2018
Q2 | $5K | Sell |
53
-2,627
| -98% | -$461K | ﹤0.01% | 4804 |
|
|
2018
Q1 | $519K | Buy |
+2,680
| New | +$500K | 0.01% | 2036 |
|
|
2017
Q3 | – | Sell |
-307
| Closed | -$11K | – | 4945 |
|
|
2017
Q2 | $11K | Sell |
307
-800
| -72% | -$28.7K | ﹤0.01% | 4176 |
|
|
2017
Q1 | $78K | Buy |
+1,107
| New | +$64.6K | ﹤0.01% | 3130 |
|
|
2016
Q3 | – | Sell |
-70
| Closed | -$12K | – | 4677 |
|
|
2016
Q2 | $12K | Hold |
70
| – | – | ﹤0.01% | 4007 |
|
|
2016
Q1 | $13K | Hold |
70
| – | – | ﹤0.01% | 3923 |
|
|
2015
Q4 | $25K | Sell |
70
-31
| -31% | -$12.2K | ﹤0.01% | 3801 |
|
|
2015
Q3 | $53K | Buy |
101
+98
| +3,267% | +$149K | ﹤0.01% | 3489 |
|
|
2015
Q2 | $8K | Hold |
3
| – | – | ﹤0.01% | 4359 |
|
|
2015
Q1 | $8K | Sell |
3
-11
| -79% | -$22.7K | ﹤0.01% | 4224 |
|
|
2014
Q4 | $28K | Sell |
14
-68
| -83% | -$131K | ﹤0.01% | 3766 |
|
|
2014
Q3 | $162K | Sell |
82
-57
| -41% | -$141K | ﹤0.01% | 2548 |
|
|
2014
Q2 | $494K | Buy |
139
+82
| +144% | +$268K | 0.01% | 1651 |
|
|
2014
Q1 | $213K | Sell |
57
-39
| -41% | -$144K | ﹤0.01% | 2396 |
|
|
2013
Q4 | $314K | Buy |
96
+26
| +37% | +$102K | ﹤0.01% | 2030 |
|
|
2013
Q3 | $292K | Sell |
70
-15
| -18% | -$60.4K | 0.01% | 2055 |
|
|
2013
Q2 | $285K | Buy |
+85
| New | +$323K | 0.01% | 1838 |
|
Other funds holding GYRE
SS
Group One Trading's GYRE Position: Q2 2025 in Review
Group One Trading sold out of Gyre Therapeutics (GYRE) in Q2 2025, closing a stake of 485 shares — an estimated $3.74K sold.
Group One Trading first reported a position in GYRE in Q2 2013 and held it in 24 quarters. The position peaked at $247K in Q2 2014. 48 funds tracked by Wall St. Rank hold GYRE as of Q2 2025.
- Group One Trading reported no remaining Gyre Therapeutics position as of Q2 2025 after selling out during the quarter.
- Group One Trading sold 485 Gyre Therapeutics shares in Q2 2025, an estimated $3.74K.
- Group One Trading first reported a position in Gyre Therapeutics in Q2 2013 and held it in 24 quarters.
- Group One Trading's Gyre Therapeutics position peaked at $247K in Q2 2014.
- 48 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2025.
Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.